Tops & Flops Stocks
| Security ▼ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| M1 Kliniken AG | 8.960% | -12.073% | -22.093% | 126.351% | 50.901% | 54.378% | - |
| Luz Saude SGPS SA | - | - | - | - | - | - | - |
| Luye Pharma Group | -2.400% | -2.907% | 7.051% | -22.326% | -21.596% | -39.820% | -49.008% |
| Luna Innovations Inc. | -1.080% | - | - | - | - | - | - |
| Lumos Pharma Inc. | 1.980% | -0.962% | -8.850% | -42.135% | -29.452% | -75.765% | -83.625% |
| Luminex Corp. Del | - | - | - | - | - | - | - |
| Lifeist Wellness Inc. | - | - | - | - | - | - | - |
| Lexicon Pharmaceuticals Inc. | 0.890% | 5.162% | 12.884% | -22.431% | 22.536% | -57.513% | -66.428% |
| Le Noble Age | 0.800% | 1.633% | 3.750% | -15.017% | 26.653% | -52.023% | - |
| Lemaitre Vascular Inc | 1.340% | 1.361% | 2.759% | 20.161% | 43.269% | 43.269% | - |
| Lantheus Holdings Inc | 0.410% | -4.544% | 1.941% | -13.465% | 30.540% | - | - |
| Lansen Pharmaceutical Holdings Ltd | 0.830% | - | - | - | - | - | - |
| Lannett Co. Inc. | -86.360% | - | - | - | - | - | - |
| Laboratorios Farmaceuticos | -0.180% | -4.969% | -9.121% | 100.482% | 37.407% | 47.780% | - |
| Laboratorio Reig Jofre S.A. | -2.460% | -8.387% | 4.797% | 9.653% | 28.507% | -39.186% | 26.222% |
| Kyowa Hakko Kirin Co. Ltd. | -0.640% | -1.266% | 4.000% | -9.302% | 5.405% | -46.575% | -2.500% |
| Kura Oncology Inc | 2.110% | 3.289% | -3.332% | 93.878% | 48.438% | 6.145% | 11.529% |
| Krystal Biotech | -0.360% | 0.181% | 10.630% | 50.909% | 43.103% | - | - |
| Kindred Biosciences Inc. | 0.650% | - | - | - | - | - | - |
| Kiadis Pharma Bv | 0.370% | - | - | - | - | - | - |
| Kezar Life Sciences | -0.840% | -3.252% | -8.462% | -71.667% | -32.000% | -86.353% | - |
| Kewaun.scientific Dl2,50 | 1.890% | -8.621% | -10.674% | 123.944% | 31.405% | 176.522% | 101.777% |
| Kempharm Inc | -1.320% | - | - | - | - | - | - |
| Karyopharm Therapeutics Inc. | 10.500% | 12.687% | 4.892% | -46.363% | 23.020% | -88.736% | - |
| Karo Pharma AB | -0.180% | - | - | - | - | - | - |